[Stem cell therapy in acute myocardial infarction]

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Cell Therapy

Background:

• Left ventricular remodeling post-myocardial infarction (MI) is a primary driver of heart failure and mortality.
• Bone marrow-derived cells show potential for aiding myocardial repair after MI.
• Current therapeutic strategies for MI often fall short in fully restoring cardiac function.

Purpose of the Study:

• To evaluate the safety and efficacy of autologous mononuclear bone marrow cell transplantation in patients with MI.
• To assess the impact of this cell therapy on cardiac function, myocardial perfusion, and metabolism.
• To explore the underlying mechanisms of therapeutic benefit, including myocardial regeneration and neovascularization.

Main Methods:

• Selective intracoronary transplantation of autologous, mononuclear bone marrow cells.
• Clinical assessment of heart function, myocardial perfusion, and metabolic parameters post-transplantation.
• Evaluation of potential cell-mediated mechanisms contributing to cardiac repair.

Main Results:

• Intracoronary transplantation of autologous bone marrow cells was found to be safe in the clinical setting.
• The procedure demonstrated apparent effectiveness in improving heart function, myocardial perfusion, and metabolism.
• Therapeutic benefits are potentially linked to bone marrow cell-induced myocardial regeneration and neovascularization.

Conclusions:

• Autologous mononuclear bone marrow cell transplantation is a safe and potentially effective therapy for patients following myocardial infarction.
• This cell-based approach may offer a novel strategy to combat infarct-related heart failure by promoting cardiac repair.
• Further research is warranted to fully elucidate the regenerative and angiogenic potential of bone marrow cells in cardiac healing.